The COVID-19 Pandemic – Products

A new study has shown graphene-based biosensors could play a major role in detecting Interleukin-10 (IL-10), an important inflammation regulator, at significantly lower levels than previous point-of-care measurements.

Carterra Inc. launched its latest HT-SPR instrument, the LSAXT, at the Society for Laboratory Automation and Screening (SLAS) Conference and Exhibition in San Diego, CA.

Co-funded by Innovate UK, Aseptika is collaborating with the University of Birmingham, University of York and the National Audit of Cardiac Rehabilitation to study the impact of a hybrid delivery of cardiac rehabilitation.

MIP Discovery has announced it has secured a significant grant of funds from the Bill & Melinda Gates Foundation.

BioGrad is to open the UK's second-largest biobank facility in Liverpool, as part of a £7.6m investment into a new headquarters at Wavertree Technology Park.

Lipid nanoparticles (LNPs), comprised of ionizable lipids, are used to deliver oligonucleotides to work as therapeutics or to stimulate the immune system, as in the initial mRNA-based COVID vaccines.

Particle Works continues to pave the way for particle perfection with the highly anticipated launch of its second revolutionary platform, the Automated Library Synthesis (ALiS) System.

The Applied Biosystems Absolute Q SARS-CoV-2 Wastewater Surveillance Kit is designed to provide rapid and consistent absolute quantitation of relevant SARS-CoV-2 targets from wastewater samples using digital PCR.

This year, the Biochemical Analytics Prize, endowed with 50,000 euros, will be
awarded to biochemistry professor, Dr Kai Simons and analytical chemist, Dr
Andrej Shevchenko, as well as to Professor Andreas Greinacher, a transfusion
medicine physician.

Takara Bio Europe announced today a partnership with the German company BioeXsen GmbH for the distribution of in vitro diagnostic solutions for the qPCR detection of common pathogens found in respiratory tract infections.